These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24890273)

  • 21. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.
    Lau TK; Jiang F; Chan MK; Zhang H; Lo PS; Wang W
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):434-7. PubMed ID: 23035860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status.
    Simpson JL
    Fertil Steril; 2013 Mar; 99(4):1124-34. PubMed ID: 23499003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive prenatal diagnosis empowered by high-throughput sequencing.
    Chiu RW; Lo YM
    Prenat Diagn; 2012 Apr; 32(4):401-6. PubMed ID: 22467171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study.
    Dhallan R; Guo X; Emche S; Damewood M; Bayliss P; Cronin M; Barry J; Betz J; Franz K; Gold K; Vallecillo B; Varney J
    Lancet; 2007 Feb; 369(9560):474-81. PubMed ID: 17292767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes.
    Wapner RJ; Babiarz JE; Levy B; Stosic M; Zimmermann B; Sigurjonsson S; Wayham N; Ryan A; Banjevic M; Lacroute P; Hu J; Hall MP; Demko Z; Siddiqui A; Rabinowitz M; Gross SJ; Hill M; Benn P
    Am J Obstet Gynecol; 2015 Mar; 212(3):332.e1-9. PubMed ID: 25479548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new era in noninvasive prenatal testing.
    Sehnert AJ; Rava RP; Bianchi DW
    N Engl J Med; 2013 Nov; 369(22):2164-5. PubMed ID: 24283244
    [No Abstract]   [Full Text] [Related]  

  • 31. A new era in noninvasive prenatal testing.
    Ashwood ER; Palomaki GE
    N Engl J Med; 2013 Nov; 369(22):2164. PubMed ID: 24283243
    [No Abstract]   [Full Text] [Related]  

  • 32. A new era in noninvasive prenatal testing.
    Greene MF; Mello MM; Morain S
    N Engl J Med; 2013 Nov; 369(22):2165. PubMed ID: 24283242
    [No Abstract]   [Full Text] [Related]  

  • 33. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism.
    Choi H; Lau TK; Jiang FM; Chan MK; Zhang HY; Lo PS; Chen F; Zhang L; Wang W
    Prenat Diagn; 2013 Feb; 33(2):198-200. PubMed ID: 23192749
    [No Abstract]   [Full Text] [Related]  

  • 35. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
    Bianchi DW; Platt LD; Goldberg JD; Abuhamad AZ; Sehnert AJ; Rava RP;
    Obstet Gynecol; 2012 May; 119(5):890-901. PubMed ID: 22362253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis.
    Liao GJ; Chiu RW; Lo YM
    Pathology; 2012 Feb; 44(2):69-72. PubMed ID: 22198255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience.
    Sago H; Sekizawa A;
    Prenat Diagn; 2015 Apr; 35(4):331-6. PubMed ID: 25408438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amniotic fluid and advances in prenatal diagnosis.
    Schwartz M; Schwartz S; Wenk RE; Cohen M
    Clin Lab Med; 1985 Jun; 5(2):371-87. PubMed ID: 2411461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy-Number Variation and False Positive Prenatal Screening Results.
    Chudova DI; Sehnert AJ; Bianchi DW
    N Engl J Med; 2016 Jul; 375(1):97-8. PubMed ID: 27406371
    [No Abstract]   [Full Text] [Related]  

  • 40. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result.
    Long AA; Abuhamad AZ; Warsof SL
    Clin Lab Med; 2016 Jun; 36(2):249-59. PubMed ID: 27235910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.